Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy

他のバージョン（1件）を表示する

Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by mutations in the survival motor neuron 1 (<i>SMN2</i>) gene. All patients have at least one copy of a paralog, <i>SMN2</i>, but a C-to-T transition in this gene results in exon 7 skipping in a majority of tra...

書誌詳細
主要な著者:	Winkelsas, AM, Grunseich, C, Harmison, GG, Chwalenia, K, Rinaldi, C, Hammond, SM, Johnson, K, Bowerman, M, Arya, S, Talbot, K, Wood, MJ, Fischbeck, KH
フォーマット:	Journal article
言語:	English
出版事項:	Cell Press 2021

類似資料

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
著者:: Audrey M. Winkelsas, 等
出版事項: (2021-03-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
著者:: Winkelsas, AM
出版事項: (2020)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
著者:: Bowerman, M, 等
出版事項: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
著者:: Bowerman, M, 等
出版事項: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
著者:: Melissa Bowerman, 等
出版事項: (2017-08-01)

Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients
著者:: Christopher Grunseich, 等
出版事項: (2014-10-01)

Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
著者:: Yuri Yépez, 等
出版事項: (2020-06-01)

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
著者:: Darija Šoltić, 等
出版事項: (2020-03-01)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
著者:: Wood, M, 等
出版事項: (2017)

SMN post-translational modifications in spinal muscular atrophy
著者:: Giulietta M. Riboldi, 等
出版事項: (2023-02-01)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
著者:: Wishart, T, 等
出版事項: (2010)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
出版事項: (2020-04-01)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
著者:: Niko Hensel, 等
出版事項: (2020-02-01)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
著者:: Li-Kai Tsai
出版事項: (2012-01-01)

Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
著者:: A. I. Vlasenko, 等
出版事項: (2024-12-01)

A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN
著者:: Rademacher, S, 等
出版事項: (2020)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
著者:: Valeria Valsecchi, 等
出版事項: (2023-11-01)

The spinal muscular atrophy disease protein SMN is linked to the Golgi network.
著者:: Chen-Hung Ting, 等
出版事項: (2012-01-01)

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
著者:: Tejal Aslesh, 等
出版事項: (2022-01-01)

Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
著者:: Fabián Lombillo-Alfonso, 等
出版事項: (2020-01-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
著者:: Fabián Lombillo, 等
出版事項: (2019-05-01)

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
著者:: Claribel D Wee, 等
出版事項: (2014-01-01)

What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages?
著者:: Ines Tapken, 等
出版事項: (2024-05-01)

Spinal muscular atrophy.
著者:: Talbot, K, 等
出版事項: (2001)

A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN
著者:: Sebastian Rademacher, 等
出版事項: (2020-11-01)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
著者:: Owen, N, 等
出版事項: (2002)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
著者:: Niba, Emma Tabe Eko, 等
出版事項: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
著者:: Niba, Emma Tabe Eko, 等
出版事項: (2022)

P719: SMN1 deletion and silent carrier screening for spinal muscular atrophy
著者:: Poh San Lai, 等
出版事項: (2024-01-01)

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
著者:: Matthew E.R. Butchbach, 等
出版事項: (2007-08-01)

The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
著者:: W. Arnold, 等
出版事項: (2016-03-01)

Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
著者:: Anderton Ryan, 等
出版事項: (2014-03-01)

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
著者:: Amparo Garcia-Lopez, 等
出版事項: (2018-05-01)

P423: SMN1 SMN2 gene-specific sequencing enhances the clinical sensitivity of spinal muscular atrophy diagnostic testing
著者:: Matthew Avenarius, 等
出版事項: (2023-01-01)

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
著者:: Hammond, S, 等
出版事項: (2016)

PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice
著者:: Kordala, AJ, 等
出版事項: (2023)

In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology
著者:: Paola Bernabò, 等
出版事項: (2017-10-01)

Chapter 16 Spinal Muscular Atrophy
著者:: Talbot, K, 等
出版事項: (2003)

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy
著者:: Leow, Damien Meng-Kiat, 等
出版事項: (2024)

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts
著者:: Ilaria Signoria, 等
出版事項: (2024-12-01)